Propiedad y actividad de insiders de Alector, Inc. (ALEC): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.93 |
| Capitalización | $214M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $50.8M | $32.5M | $65.5M | $89.6M | $50.0M | $329.2M | $154.3M | $74.6M | $33.0M | $65.8M |
| Inversiones a Corto | 0 | 0 | $224.9M | $263.4M | $363.3M | $406.1M | $558.5M | $474.3M | $380.4M | $190.2M |
| Cuentas por Cobrar | $218000 | $200.2M | 0 | 0 | 0 | $7.4M | $2.6M | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $51.2M | $233.0M | $293.2M | $357.4M | $421.5M | $749.7M | $726.4M | $565.8M | $424.8M | $266.5M |
| Inmovilizado Material | $2.5M | $2.8M | $10.9M | $62.3M | $62.7M | $57.9M | $53.3M | $47.1M | $37.1M | $24.6M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $54.1M | $236.1M | $308.4M | $421.9M | $488.3M | $814.7M | $787.6M | $621.8M | $468.3M | $293.2M |
| Cuentas por Pagar | $1.2M | $1.1M | $126000 | $278000 | $3.0M | $4.7M | $4.2M | $3.8M | $2.2M | $1.7M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $366000 |
| Pasivos Corrientes | $1.5M | $27.4M | $13.0M | $62.0M | $68.1M | $139.6M | $93.8M | $177.9M | $125.1M | $69.5M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $9.4M | $9.3M |
| Pasivos Totales | $79.0M | $288.1M | $405.8M | $227.2M | $220.7M | $513.9M | $573.2M | $487.7M | $341.5M | $262.6M |
| Reservas | -$29.7M | -$62.2M | -$114.4M | -$219.8M | -$410.0M | -$446.4M | -$579.7M | -$710.1M | -$829.1M | -$972.1M |
| Patrimonio Neto | -$24.9M | -$52.0M | -$97.4M | $194.7M | $267.5M | $300.7M | $214.4M | $134.2M | $126.8M | $30.6M |
| Deuda Total | 0 | 0 | 0 | $48.0M | $51.3M | $47.6M | $43.3M | $38.9M | $42.5M | $36.2M |
| Deuda Neta | -$50.8M | -$32.5M | -$290.4M | -$305.0M | -$362.1M | -$687.6M | -$669.5M | -$509.9M | -$370.9M | -$219.8M |
| Capital Circulante | $49.7M | $205.6M | $280.1M | $295.5M | $353.4M | $610.2M | $632.6M | $387.9M | $299.8M | $196.9M |
Salud financiera
| Deuda / Patrimonio | -3.29 |
| Ratio corriente | 5.26 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -5.04 |
Rentabilidad
| Rentabilidad sobre capital | -531.04% |
| Rentabilidad sobre capital invertido | -67.56% |
| Rentabilidad sobre activos | -58.10% |
| Margen bruto | -360.92% |
| Margen operativo | -914.56% |
| Margen neto | -850.13% |
Empresas relacionadas: ABOS · APLT · CRBP · FATE · IRD · MOLN · NKTX
Explorar sector: Healthcare · Biotechnology
Más secciones de ALEC: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones